Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice?
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Lung cancer computed tomography (CT) screening trials using low-dose CT have repeatedly demonstrated a reduction in the number of lung cancer deaths in the screening group compared to a control group. With various countries currently considering the implementation of lung cancer screening, recurring discussion points are, among others, the potentially high false positive rates, cost-effectiveness, and the availability of radiologists for scan interpretation. Artificial intelligence (AI) has the potential to increase the efficiency of lung cancer screening. We discuss the performance levels of AI algorithms for various tasks related to the interpretation of lung screening CT scans, how they compare to human experts, and how AI and humans may complement each other. We discuss how AI may be used in the lung cancer CT screening workflow according to the current evidence and describe the additional research that will be required before AI can take a more prominent role in the analysis of lung screening CT scans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ImageNet classification with deep convolutional neural networks
Krizhevsky, A., Sutskever, I., & Hinton, G. E. (2017) · Communications of the ACM · doi:10.1145/3065386 · Cited by 112,155
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064 · cited 8×
“These low-dose CTs were used for most lung cancer screening trials, including the NLST (5).”
BackgroundMethodInfluentialReduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
de Koning, H. J., van der Aalst, C. M., de Jong, P. A., Scholten, E. T., Nackaerts, K., Heuvelmans, M. A., Lammers, J.-W. J., Weenink, C., Yousaf-Khan, U., Horeweg, N., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911793 · Cited by 3,624 · cited 2×
“The results of the NELSON trial showed that growth-rate assessment for indeterminate nodules is an effective way to reduce the false positive rate to approximately 2% (6).”
BackgroundSelf-citationArmato, S. G., McLennan, G., Bidaut, L., McNitt‐Gray, M. F., Meyer, C. R., Reeves, A. P., Zhao, B., Aberle, D. R., Henschke, C. I., Hoffman, E. A., et al. (2011) · Medical Physics · doi:10.1118/1.3528204 · Cited by 2,887 · cited 1×
“To account for these limitations, the Lung Nodule Analysis 2016 (LUNA16) challenge was set up using 888 scans with 1,186 nodule annotations from the Lung Image Database Consortium (LIDC) and Image Database Resource Initiative (IDRI) database for training and testing (22,26).”
MethodArdila, D., Kiraly, A. P., Bharadwaj, S., Choi, B., Reicher, J. J., Peng, L., Tse, D., Etemadi, M., Ye, W., Corrado, G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0447-x · Cited by 2,167 · cited 3×
“(49) is a good example where the analysis of multiple scans led to a performance on par with or better than radiologists.”
BackgroundMethodInfluentialAbràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0040-6 · Cited by 1,638 · cited 1×
“The first fully autonomous AI algorithm that is able to perform diagnostic assessment without supervision of an expert clinician—an AI system called IDx-DR which analyzes fundus photographs in a primary care setting to detect diabetic retinopathy—has recently been approved by the FDA (70).”
BackgroundArtificial intelligence, bias and clinical safety
Challen, R., Denny, J., Pitt, M., Gompels, L., Edwards, T., & Tsaneva-Atanasova, K. (2019) · BMJ Quality & Safety · doi:10.1136/bmjqs-2018-008370 · Cited by 956 · cited 1×
“Indications for ideal statistical and sample size considerations when testing such algorithms have been described (72).”
BackgroundAddressing bias in artificial intelligence in health care
Parikh, R. B., Teeple, S., & Navathe, A. S. (2019) · JAMA · doi:10.1001/jama.2019.18058 · Cited by 764
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study
Hosny, A., Parmar, C., Coroller, T. P., Grossmann, P., Zeleznik, R., Kumar, A., Bussink, J., Gillies, R. J., Mak, R. H., & Aerts, H. J. W. L. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002711 · Cited by 579 · cited 1×
“Though there are algorithms which were designed to predict the time of death from a scan (66-69), there is a lack of appropriate data to perform studies which attempt to predict the risk that lung cancer progression will be the cause of death.”
Questions for artificial intelligence in health care
Maddox, T. M., Rumsfeld, J. S., & Payne, P. R. O. (2019) · JAMA · doi:10.1001/jama.2018.18932 · Cited by 385 · cited 1×
“Though various papers have highlighted the importance of extensive testing before the implementation of AI into practice (73-76), RCTs for AI software are not commonly performed and are not mandatory for regulatory approval.”
Background
Cited by
Artificial intelligence and machine learning in cancer imaging
Koh, D.-M., Papanikolaou, N., Bick, U., Illing, R., Kahn, C. E., Kalpathi-Cramer, J., Matos, C., Martí-Bonmatí, L., Miles, A., Mun, S. K., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00199-0 · Cited by 311
Application of Artificial Intelligence in Lung Cancer
Chiu, H.-Y., Chao, H.-S., & Chen, Y.-M. (2022) · Cancers · doi:10.3390/cancers14061370 · Cited by 138
Quanyang, W., Yao, H., Sicong, W., Linlin, Q., Zewei, Z., Donghui, H., Hongjia, L., & Shijun, Z. (2024) · Cancer Medicine · doi:10.1002/cam4.7140 · Cited by 111
THONG, L. T., CHOU, H. S., CHEW, H. S. J., & LAU, Y. (2023) · Lung Cancer · doi:10.1016/j.lungcan.2022.12.002 · Cited by 67
Vaidhya Venkadesh, K., Aleef, T. A., Scholten, E. T., Saghir, Z., Silva, M., Sverzellati, N., Pastorino, U., van Ginneken, B., Prokop, M., & Jacobs, C. (2023) · Radiology · doi:10.1148/radiol.223308 · Cited by 32
Self-citation
Metadata
- Authors
- Schreuder, A., Scholten, E. T., van Ginneken, B., & Jacobs, C.
- Venue
- Translational Lung Cancer Research
- Publisher
- AME Publishing Company
- Published
- 2021-05
- Volume
- 10
- Issue
- 5
- Pages
- 2378-2388
- ISSN
- 2218-6751 (ISSN-L)
- 2226-4477
- OpenAlex
- W3041084338
- Cited by
- 85
- References
- 13
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice? https://app.cochat.ai/papers/10.21037/tlcr-2020-lcs-06
- The paper
- Schreuder, A., Scholten, E. T., van Ginneken, B., & Jacobs, C. (2021). Artificial intelligence for detection and characterization of pulmonary nodules in lung cancer CT screening: ready for practice? Translational Lung Cancer Research. https://doi.org/10.21037/tlcr-2020-lcs-06
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.